These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2661491)

  • 21. Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs.
    Regenthal R; Krueger M; Koeppel C; Preiss R
    J Clin Monit Comput; 1999 Dec; 15(7-8):529-44. PubMed ID: 12578052
    [No Abstract]   [Full Text] [Related]  

  • 22. [Iatrogenic nosocomial drug-induced conditions: where is the risk?].
    Schmitt E
    Presse Med; 1999 May; 28(18):970-2. PubMed ID: 10366935
    [No Abstract]   [Full Text] [Related]  

  • 23. Is current drug safety an issue?
    Besag FM
    Curr Drug Saf; 2007 Jan; 2(1):1-4. PubMed ID: 18690943
    [No Abstract]   [Full Text] [Related]  

  • 24. Imputability of Adverse Events to Anticancer Drugs.
    Moreau-Bachelard C; Coquan E; Le Tourneau C
    N Engl J Med; 2019 May; 380(19):1873-1874. PubMed ID: 31067382
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of high-dose intravenous immunoglobulin (IVIG) in a 5% and a 10% solution does not reveal a significantly different spectrum of side-effects.
    Rappold LC; Denk K; Enk AH; Hadaschik EN
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):e186-e188. PubMed ID: 26551028
    [No Abstract]   [Full Text] [Related]  

  • 26. TOX-RISK: a program for fitting dose-response formulae and extrapolating between species.
    Crouch EA
    Risk Anal; 1989 Dec; 9(4):599-603. PubMed ID: 2608950
    [No Abstract]   [Full Text] [Related]  

  • 27. Questions of the end of the century and millennium. Ecologic pharmacology.
    Dobrescu D
    Rom J Physiol; 1994; 31(1-4):19-24. PubMed ID: 8640364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of adverse reactions to new drugs. IV--Verification of suspected adverse reactions.
    Venning GR
    Br Med J (Clin Res Ed); 1983 Feb; 286(6364):544-7. PubMed ID: 6402143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drugs and liver damage].
    Dölle W
    Dtsch Med J; 1972 Nov; 23(11):643-7. PubMed ID: 4660034
    [No Abstract]   [Full Text] [Related]  

  • 30. New approach reduces side effects of high-dose chemotherapy for breast cancer.
    Oncology (Williston Park); 1999 Sep; 13(9):1316. PubMed ID: 10509326
    [No Abstract]   [Full Text] [Related]  

  • 31. Side-effect reduction by use of drugs that bind to separate but equivalent binding sites.
    Ehrenstein G; Huang LY
    Science; 1981 Dec; 214(4527):1365-6. PubMed ID: 7313696
    [No Abstract]   [Full Text] [Related]  

  • 32. Drugs with aging. Misperceptions about medications.
    Mayo Clin Health Lett; 2014 Dec; 32(12):7. PubMed ID: 26087529
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA mulls changes to bioequivalence standards.
    Traynor K
    Am J Health Syst Pharm; 2010 Jun; 67(11):864. PubMed ID: 20484205
    [No Abstract]   [Full Text] [Related]  

  • 34. Dose-response analysis of combination preparations.
    Unkelbach HD; Wolf T
    Stat Med; 1985; 4(1):77-85. PubMed ID: 3992075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the dose, time, susceptibility (DoTS) classification scheme for adverse drug reactions in pharmacovigilance planning.
    Callréus T
    Drug Saf; 2006; 29(7):557-66. PubMed ID: 16808549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improved procedure for assaying irritants. The scarification test.
    Frosch PJ; Kligman AM
    Curr Probl Dermatol; 1978; 7():69-79. PubMed ID: 752459
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse Drug Reactions: Type A (Intrinsic) or Type B (Idiosyncratic).
    Iasella CJ; Johnson HJ; Dunn MA
    Clin Liver Dis; 2017 Feb; 21(1):73-87. PubMed ID: 27842776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More than they bargained for. Adverse drug effects.
    Carruth AK; Boss BJ
    J Gerontol Nurs; 1990 Jul; 16(7):27-31. PubMed ID: 2370429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic drug reactions.
    Perez V; Schaffner F; Popper H
    Prog Liver Dis; 1972; 4():597-625. PubMed ID: 4569012
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug-induced panmyelopathies].
    Heimpel H; Kern P
    Blut; 1976 Jul; 33(1):1-10. PubMed ID: 61773
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.